T Mora, I Sánchez-Collado, J Mullol, R Muñoz-Cano, P Ribó, A Valero
{"title":"Prevalence of Atopic Dermatitis in the Adult Population of Catalonia, Spain: A Large-Scale, Retrospective, Population-Based Study.","authors":"T Mora, I Sánchez-Collado, J Mullol, R Muñoz-Cano, P Ribó, A Valero","doi":"10.18176/jiaci.0899","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Studies on the prevalence of atopic dermatitis (AD) in adults in general populations are scarce worldwide. We performed a retrospective population-based observational cohort study of 537 098 adult patients diagnosed with AD in Catalonia, Spain, a larger population than in previous studies. Objectives: To study the prevalence of AD by age, sex, disease severity, multimorbidity, serum total immunoglobin E (tIgE), and appropriate medical treatment (AMT) for the population of Catalonia.</p><p><strong>Methods: </strong>The study population comprised adult individuals (≥18 years) diagnosed with AD according to medical records at different health care levels (primary, hospital, emergency) in the Catalan Health System. Statistical analyses were conducted to evaluate sociodemographic characteristics, prevalence, multimorbidity, serum tIgE, and AMT.</p><p><strong>Results: </strong>The prevalence of AD in the adult Catalan population was 8.7%, being higher for nonsevere disease (8.5%) than for severe disease (0.2%) and in females (10.1%) than in males (7.3%). Topical corticosteroids were the most prescribed drug (66.5%), and treatment was prescribed more frequently in severe AD patients, especially systemic corticosteroids (63.8%) and immunosuppressants (60.7%). More than half of severe AD patients (52.2%) had serum tIgE ≥100 kU/L, and higher values were observed for those with multimorbidity. The most frequent comorbid respiratory diseases were acute bronchitis (13.7%), allergic rhinitis (12.1%), and asthma (8.6%).</p><p><strong>Conclusions: </strong>We provide new and robust evidence of the prevalence of AD and related characteristics in adults using a large-scale population-based study and a more significant cohort of individuals.</p>","PeriodicalId":50173,"journal":{"name":"Journal of Investigational Allergology and Clinical Immunology","volume":" ","pages":"225-232"},"PeriodicalIF":6.1000,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Investigational Allergology and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18176/jiaci.0899","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/2/23 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Studies on the prevalence of atopic dermatitis (AD) in adults in general populations are scarce worldwide. We performed a retrospective population-based observational cohort study of 537 098 adult patients diagnosed with AD in Catalonia, Spain, a larger population than in previous studies. Objectives: To study the prevalence of AD by age, sex, disease severity, multimorbidity, serum total immunoglobin E (tIgE), and appropriate medical treatment (AMT) for the population of Catalonia.
Methods: The study population comprised adult individuals (≥18 years) diagnosed with AD according to medical records at different health care levels (primary, hospital, emergency) in the Catalan Health System. Statistical analyses were conducted to evaluate sociodemographic characteristics, prevalence, multimorbidity, serum tIgE, and AMT.
Results: The prevalence of AD in the adult Catalan population was 8.7%, being higher for nonsevere disease (8.5%) than for severe disease (0.2%) and in females (10.1%) than in males (7.3%). Topical corticosteroids were the most prescribed drug (66.5%), and treatment was prescribed more frequently in severe AD patients, especially systemic corticosteroids (63.8%) and immunosuppressants (60.7%). More than half of severe AD patients (52.2%) had serum tIgE ≥100 kU/L, and higher values were observed for those with multimorbidity. The most frequent comorbid respiratory diseases were acute bronchitis (13.7%), allergic rhinitis (12.1%), and asthma (8.6%).
Conclusions: We provide new and robust evidence of the prevalence of AD and related characteristics in adults using a large-scale population-based study and a more significant cohort of individuals.
背景和目的:在全球范围内,有关特应性皮炎(AD)在普通人群中的成人患病率的研究很少。我们对加泰罗尼亚(西班牙)537,098 名确诊为特应性皮炎的成年患者进行了一项基于人群的回顾性队列观察研究,该研究的人群规模大于以往的研究。目的是研究按年龄、性别、疾病严重程度、多病症、血清总免疫球蛋白 E (tIgE) 和接受适当治疗 (AMT) 划分的加泰罗尼亚人群的 AD 患病率:方法:纳入加泰罗尼亚卫生系统(CHS)不同医疗保健级别(初级、医院、急诊)的医疗记录中确诊为注意力缺失症的成年人(≥18 岁)。对社会人口学特征、发病率、多病症、血清 tIgE 和 AMT 进行了统计分析:加泰罗尼亚成年人口中确诊的注意力缺失症总发病率为 8.7%,非重度人群(8.5%)高于重度人群(0.2%),女性(10.1%)高于男性(7.3%)。外用皮质类固醇激素是最常用的处方药(66.5%),在严重AD患者中,所有处方药的使用率都较高,尤其是全身性皮质类固醇激素(63.8%)和免疫抑制剂(60.7%)。半数以上(52.2%)的重症AD患者报告血清tIgE≥100 KU/L,患有多种疾病的患者血清tIgE值更高。急性支气管炎(13.7%)、过敏性鼻炎(12.1%)和哮喘(8.6%)是最常见的合并呼吸系统疾病:我们的研究通过大规模的人群研究和更重要的个体队列,为成人注意力缺失症的患病率和相关特征提供了新的有力证据。
期刊介绍:
The Journal of Investigational Allergology and Clinical Immunology (J Investig Allergol Clin Immunol) provides an attractive and very active forum for basic and clinical research in allergology and clinical immunology.Journal of Investigational Allergology and Clinical Immunology publishes original works, reviews, short communications and opinions.